Analysis of Birth Outcomes of Swedish, Danish and Finnish Women Exposed to Remicade With Inflammatory Bowel Disease, Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, and Psoriasis

NCT00658827 · clinicaltrials.gov ↗
COMPLETED
Status
370
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Janssen Biotech, Inc.

Collaborators